Safety of tranexamic acid in thrombotic adverse events and seizure in hemorrhagic patients: a systematic review and meta-analysis
Not Applicable
- Conditions
- Patients with bleeding in any underlying disease
- Registration Number
- JPRN-UMIN000039611
- Lead Sponsor
- Osaka General Medical Center, Division of Trauma and Surgical Critical Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
Not provided
Exclusion Criteria
Studies done with animals will be excluded from this review.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The occurrence of any thrombotic adverse events, including acute coronary syndrome (ACS), stroke/transient ischemic attack (TIA), and venous thromboembolism (VTE), and seizure.
- Secondary Outcome Measures
Name Time Method The occurrence of ACS, stroke/TIA, and VTE will be assessed separately.